https://www.moneycontrol.com/news/business/companies/strides-pharma-to-sell-its-singapore-manufacturing-facility-for-15-million-11614331.html
0
0
34 words
0
Comments
Additionally, as part of the transaction, Rxilient Biohub will assume the long-term lease obligation associated with the manufacturing site from Strides
You are the first to view
Create an account or login to join the discussion